Considering all the patients showing downregulation of total HER4 in their tumor tissue, in 82% of these NRG4 was also downregulation and in 86% one or more of the EGFR-shared ligands (HB-EGF, epiregulin, betacellulin) was upregulated. This evidence concerns the gene EREG and neoplasm.